Exploring the role of miR-125b-5p as a pro-inflammatory factor in Alzheimer's disease pathology
Authors:
- 25 November 2024
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 102 (4) , 1224-1238
Abstract
Background: Alzheimer's disease (AD) is a common neurodegenerative disease, where neuroinflammation significantly influences its pathophysiology by driving the disease's pathological cascade. As a pro-inflammatory regulator, miR-125b-5p contributes to AD progression, though its precise role and mechanisms remain unclear. Objective: We aims to identify mRNAs significantly regulated by pro-inflammatory miR-125b-5p in AD and uncover key neuroinflammatory pathways. Methods: Target mRNAs regulated by miR-125b-5p were predicted using online databases and analyzed with two mRNA datasets to identify differentially expressed mRNAs (DEmRNAs). Enrichment analysis was conducted to explore their biological functions and pathways. The significance of DEmRNAs expression in AD-related inflammatory pathways was verified by the Wilcoxon test, predictive accuracy was assessed via area under the curves (AUCs), and novel mRNAs were identified through positive control analysis. Results: A total of 613 miR-125b-5p target mRNAs were identified, and 44 DEmRNAs were detected to be regulated by miR-125b-5p in two datasets. The 44 target DEmRNAs associated with AD include three key pathways: insulin signaling ( EXOC7, FLOT2, MKNK2), phosphatidylinositol signaling ( IP6K1, MTMR3), and phospholipase D signaling ( CYTH1, GAB2). Correlation analysis indicated strong correlations among 7 mRNAs, all showing significant differential expression, with AUCs above 0.5, confirming their predictive value. Three mRNAs ( EXOC7, IP6K1, CYTH1) were identified as novel AD-related genes. MiR-125b-5p binding sites in the 3′-UTRs of these 7 mRNAs suggest their potential roles in AD-related inflammation and signaling pathways. Conclusions: This study investigates the pro-inflammatory miR-125b-5p's role in the pathological processes of AD, highlighting its regulation of key target mRNAs and critical pathways.Keywords
Funding Information
- National Natural Science Foundation of China (62101171)
- Natural Science Foundation of Zhejiang Province (LQ22F010015)
- National Key Research and Development Program of China (2023YFC2412001)
This publication has 66 references indexed in Scilit:
- The emerging role of noncoding RNAs in neuroinflammation: Implications in pathogenesis and therapeutic approachesJournal of Cellular Physiology, 2021
- Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer’s DiseaseMolecular Neurobiology, 2021
- Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer’s disease in genes and isoformsHuman Genetics, 2020
- Unravelling the regulation of insulin transport across the brain endothelial cellDiabetologia, 2017
- The PtdIns3‐phosphatase MTMR3 interacts with mTORC1 and suppresses its activityFEBS Letters, 2015
- Regulation of Neurotropic Signaling by the Inducible, NF-kB-Sensitive miRNA-125b in Alzheimer's Disease (AD) and in Primary Human Neuronal-Glial (HNG) CellsMolecular Neurobiology, 2013
- Regulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer’s Disease (AD) BrainMolecular Neurobiology, 2012
- Deficient brain insulin signalling pathway in Alzheimer's disease and diabetesThe Journal of Pathology, 2011
- Genome wide profiling of altered gene expression in the neocortex of Alzheimer's diseaseJournal of Neuroscience Research, 2009
- GAB2 as an Alzheimer Disease Susceptibility GeneArchives of Neurology, 2009